BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17960814)

  • 21. Abnormal head nociceptive withdrawal reaction to facial nociceptive stimuli in Parkinson's disease.
    Perrotta A; Serrao M; Bartolo M; Valletta L; Locuratolo N; Pujia F; Fattapposta F; Bramanti P; Amabile GA; Pierelli F; Parisi L
    Clin Neurophysiol; 2005 Sep; 116(9):2091-8. PubMed ID: 16029959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of corticomotor excitability after maximal or sustainable-rate repetitive finger movement is impaired in Parkinson's disease and is reversed by levodopa.
    Teo WP; Rodrigues JP; Mastaglia FL; Thickbroom GW
    Clin Neurophysiol; 2014 Mar; 125(3):562-8. PubMed ID: 24095151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine agonist-induced antecollis in Parkinson's disease.
    Uzawa A; Mori M; Kojima S; Mitsuma S; Sekiguchi Y; Kanesaka T; Kuwabara S
    Mov Disord; 2009 Dec; 24(16):2408-11. PubMed ID: 19890970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pramipexole-induced antecollis in Parkinson's disease.
    Suzuki M; Hirai T; Ito Y; Sakamoto T; Oka H; Kurita A; Inoue K
    J Neurol Sci; 2008 Jan; 264(1-2):195-7. PubMed ID: 17826796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dystonia in multiple system atrophy.
    Boesch SM; Wenning GK; Ransmayr G; Poewe W
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):300-3. PubMed ID: 11861684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of auditory and vestibular dysfunction in Parkinson's disease and Multiple System Atrophy.
    Scarpa A; Cassandro C; Vitale C; Ralli M; Policastro A; Barone P; Cassandro E; Pellecchia MT
    Parkinsonism Relat Disord; 2020 Feb; 71():51-57. PubMed ID: 32032926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Orthostatic hypotension as an early finding in Parkinson's disease.
    Goldstein DS
    Clin Auton Res; 2006 Feb; 16(1):46-54. PubMed ID: 16477495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative electromyography of the external anal sphincter in Parkinson's disease and multiple system atrophy.
    Libelius R; Johansson F
    Muscle Nerve; 2000 Aug; 23(8):1250-6. PubMed ID: 10918263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upper camptocormia in Parkinson's disease: Neurophysiological and imaging findings of both central and peripheral pathophysiological mechanisms.
    Magrinelli F; Geroin C; Squintani G; Gandolfi M; Rizzo G; Barillari M; Vattemi G; Morgante F; Tinazzi M
    Parkinsonism Relat Disord; 2020 Feb; 71():28-34. PubMed ID: 31981996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myopathic dropped head syndrome: an expanding clinicopathological spectrum.
    Liao JP; Waclawik AJ; Lotz BP; Salamat SM; Beinlich BR; Brooks BR
    Am J Phys Med Rehabil; 2007 Dec; 86(12):970-6. PubMed ID: 18090438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tonic Electromyogram Density in Multiple System Atrophy with Predominant Parkinsonism and Parkinson's Disease.
    Wang Y; Shen Y; Xiong KP; He PC; Mao CJ; Li J; Wang FY; Wang YL; Huang JY; Liu CF
    Chin Med J (Engl); 2017 Mar; 130(6):684-690. PubMed ID: 28303851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myopathy causing camptocormia in idiopathic Parkinson's disease: a multidisciplinary approach.
    Spuler S; Krug H; Klein C; Medialdea IC; Jakob W; Ebersbach G; Gruber D; Hoffmann KT; Trottenberg T; Kupsch A
    Mov Disord; 2010 Apr; 25(5):552-9. PubMed ID: 20014064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of subthalamic nucleus deep brain stimulation on axial motor control and protective arm responses in Parkinson's disease.
    Visser JE; Allum JH; Carpenter MG; Esselink RA; Limousin-Dowsey P; Honegger F; Borm GF; Bloem BR
    Neuroscience; 2008 Dec; 157(4):798-812. PubMed ID: 18952153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myopathic camptocormia in a patient with levodopa unresponsive parkinsonism.
    Linazasoro G; Suárez JA
    Neurologia; 2002 Mar; 17(3):162-4. PubMed ID: 11927107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Ashour R; Jankovic J
    Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subthalamic nucleus deep brain stimulation in a patient with levodopa-responsive multiple system atrophy. Case report.
    Chou KL; Forman MS; Trojanowski JQ; Hurtig HI; Baltuch GH
    J Neurosurg; 2004 Mar; 100(3):553-6. PubMed ID: 15035294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urodynamic study for distinguishing multiple system atrophy from Parkinson disease.
    Shin JH; Park KW; Heo KO; Chung SJ; Choo MS
    Neurology; 2019 Sep; 93(10):e946-e953. PubMed ID: 31371567
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lingual protrusion dystonia: Manifestation during "on" periods in Parkinson's disease.
    Maiola R; Ramirez Gómez CC; Micheli F
    J Neurol Sci; 2016 Nov; 370():256-257. PubMed ID: 27772770
    [No Abstract]   [Full Text] [Related]  

  • 39. Focal myopathy as a cause of anterocollis in Parkinsonism.
    Lava NS; Factor SA
    Mov Disord; 2001 Jul; 16(4):754-6. PubMed ID: 11481704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin type A for Levodopa-induced cervical dyskinesias in Parkinson's disease: unfavorable risk-benefit ratio.
    Espay AJ; Vaughan JE; Shukla R; Gartner M; Sahay A; Revilla FJ; Duker AP
    Mov Disord; 2011 Apr; 26(5):913-4. PubMed ID: 21432906
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.